IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

M28 Capital Management LP

Q3 2025 Holdings

Filed 2025-11-13 | 9 holdings | $68.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Wave Life Sciences LTD(WVE)SHSY95308105$41.5M5,664,54861.0%
Invivyd Inc(IVVD)COM00534A102$10.2M9,248,25015.0%
TG Therapeutics Inc(TGTX)COM88322Q108$5.8M161,6008.6%
Fractyl Health Inc(GUTS)COM35168W103$3.0M1,856,1174.3%
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$2.3M67,4003.4%
Proqr Thrapeutics N VSHS EURON71542109$2.2M1,019,4983.2%
Rocket Pharmaceuticals Inc(RCKT)COM77313F106$1.3M385,6801.8%
Silence Therapeutics PLC(SLN)ADS82686Q101$960.7K185,1001.4%
Curis Inc(CRIS)COM231269309$865.0K521,0591.3%